Acm Research SEC Filings

ACM Research (ACMR) Form 144 notice reports a proposed sale of 60,000 common shares through Morgan Stanley Smith Barney on 09/04/2025 with an aggregate market value of $1,586,508.00. The shares were acquired and to be sold following a stock option exercise on 09/04/2025 and payment was made in cash. The filing notes 64,180,965 shares outstanding. It also discloses a recent sale by Hui Wang of 70,000 shares on 09/03/2025 for $1,873,711.00. The filer certifies they are not aware of any undisclosed material adverse information.

ACM Research, Inc. (ACMR) filed a Form 144 reporting a proposed sale of 70,000 common shares through Morgan Stanley Smith Barney LLC, scheduled approximately on 09/03/2025 on NASDAQ with an aggregate market value of $1,873,711.00. The filing shows these shares were acquired and paid for on 09/03/2025 by exercise of a stock option, with payment in cash to the issuer.

The notice states there were no other sales by the reporting person in the prior three months. The filer certifies they are unaware of any undisclosed material adverse information about the issuer. The document provides broker details and confirms the transaction source as an option exercise rather than a gift or third-party purchase.

The reporting person, Cheav Sotheara, exercised a previously issued stock option and immediately sold the acquired shares. On 08/22/2025 Mr. Cheav exercised an option with a $13.89 exercise price to purchase 11,152 shares of ACM Research Class A common stock and sold 11,152 shares that same day at $30 per share pursuant to a Rule 10b5-1 trading plan adopted May 15, 2025. After these transactions the reporting person beneficially owns 100,002 shares of Class A common stock. The Form 4 notes the underlying option covers 66,250 shares, is fully vested and exercisable, and includes a vesting schedule for remaining tranches. The reporting person is identified as Senior Vice President, Manufacturing of ACM Research (Shanghai), Inc., a subsidiary of the issuer.

Wang Jian, an officer and the Chief Executive Officer and President of ACM Research (Shanghai), Inc., reported option exercises and share sales in Form 4 filings. On 08/22/2025 he exercised 30,000 stock options with a $5.60 exercise price and immediately sold 30,000 Class A shares at $30.00, reducing his direct holdings to 253,158 shares. On 08/25/2025 he repeated the sequence—exercised 30,000 options at $5.60 and sold 30,000 shares at $32.00—leaving total direct holdings at 253,158 Class A shares. The Form notes the option was fully vested and the sales were made under a Rule 10b5-1 trading plan adopted May 20, 2025. The Form was signed by an attorney-in-fact on 08/26/2025.

ACM Research, Inc. (ACMR) Form 144 notice: An individual plans to sell 30,000 common shares through Morgan Stanley Smith Barney on NASDAQ with an aggregate market value of $960,000. The filing lists 64,180,965 shares outstanding, making the proposed sale roughly 0.0467% of outstanding shares. The securities were reported as acquired by stock option exercise with a purchase date and payment date shown as 08/25/2025. The filing also discloses a sale of 30,000 shares by Jian Wang on 08/22/2025 for gross proceeds of $900,012. The notice includes the required representation that the seller does not possess undisclosed material information.

ACM Research, Inc. (ACMR) Form 144 notice: The filer intends to sell 30,000 shares of the issuer's common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $900,012.00. The shares reported were acquired and will be paid for by cash on 08/22/2025 via a stock option exercise from the issuer. The filing shows 64,180,965 shares outstanding, lists the proposed sale date as 08/22/2025 on the NASDAQ, and reports no securities sold by the person in the past three months.

Form 144 notice for ACM Research, Inc. (ACMR) shows a proposed sale of 11,152 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $334,560.00. The shares represent a portion of 64,180,965 shares outstanding and an approximate sale date of 08/22/2025. The shares were acquired on 08/22/2025 by stock option exercise from the issuer and paid in cash. The filer reports no securities sold in the past three months and affirms they are not aware of any undisclosed material adverse information.

Charles C. Pappis, a director of ACM Research, Inc. (ACMR), was granted a stock option to buy 20,000 shares of Class A common stock at an exercise price of $24.93 per share. The option was granted with an exercise date of 08/12/2025, vests immediately prior to the issuer's 2026 annual meeting subject to continued service, and expires on 08/11/2035. After this transaction, Mr. Pappis beneficially owns 20,000 underlying shares through the option, held directly.